Ekso Bionics Holdings, Inc. (EKSO) Financial Statements
Industry: General Industrial Machinery & Equipment (Other)
In fiscal 2026, Ekso Bionics reported revenue of $71.6M, up 459.4% from $12.8M the year before. Net income was -$50.3M (a -70.3% net margin), or -$0.36 per diluted share. Gross margin was -23.9% and operating margin was -52.4%. Operating activities generated $39.1M of cash, leaving $12.2M of free cash flow. At fiscal year end, Ekso Bionics held $325.9M in total assets against $143.8M in total liabilities, including $9.7M of cash and equivalents.
Open the full interactive Ekso Bionics financials → Quarterly statements, key ratios, valuation history and price charts.
Ekso Bionics Key Stats
| Share Price | $16.31 |
|---|---|
| Market Cap | $2.26B |
| Revenue YoY Growth | +459.4% |
| 52-Week Range | $3.87 – $29.63 |
| Shares Outstanding | 3.6 million (basic, 2026 Q1) |
Ekso Bionics Income Statement
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | FY 2026 | |
|---|---|---|---|---|---|---|
| Revenue | $11.2M | $12.9M | $18.3M | $17.9M | $12.8M | $71.6M |
| Cost of Goods Sold | $4.5M | $6.7M | $9.2M | $8.4M | $6.0M | $109.1M |
| Gross Profit | $6.7M | $6.2M | $9.1M | $9.5M | $6.8M | -$17.1M |
| Operating Income | -$13.8M | -$15.6M | -$15.1M | -$10.5M | -$13.3M | -$37.5M |
| Pre-Tax Income | -$9.8M | -$15.1M | -$15.2M | -$11.3M | -$11.7M | -$49.3M |
| Income Tax | — | — | — | — | $0 | $0 |
| Net Income | -$9.8M | -$15.1M | -$15.2M | -$11.3M | -$11.7M | -$50.3M |
| Diluted EPS | -$13.20 | -$17.40 | -$16.50 | -$8.43 | -$4.91 | -$0.36 |
Ekso Bionics Quarterly Results
| 2025 Q2 | 2025 Q3 | 2025 Q4 | 2026 Q1 | |
|---|---|---|---|---|
| Revenue | $2.1M | $4.2M | $3.1M | $2.1M |
| Net Income | -$2.7M | -$1.4M | -$4.7M | -$6.9M |
| Diluted EPS | -$1.24 | -$0.54 | — | -$2.04 |
Ekso Bionics Balance Sheet
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | FY 2026 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $40.4M | $20.5M | $8.6M | $6.5M | $1.2M | $9.7M |
| Current Assets | $47.8M | $31.0M | $20.2M | $18.8M | $14.0M | $44.2M |
| Total Assets | $49.2M | $40.9M | $28.9M | $26.7M | $20.1M | $325.9M |
| Current Liabilities | $6.9M | $9.2M | $8.1M | $7.5M | $8.6M | $86.9M |
| Total Long-Term Debt | $2.0M | $6.1M | $6.1M | $5.1M | $2.0M | $3.8M |
| Total Liabilities | $11.9M | $15.5M | $16.3M | $13.9M | $11.1M | $143.8M |
| Shareholders' Equity | $37.2M | $25.4M | $12.6M | $12.7M | $9.0M | $180.0M |
Ekso Bionics Cash Flow Statement
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | FY 2026 | |
|---|---|---|---|---|---|---|
| Cash From Operations | -$11.2M | -$14.7M | -$12.1M | -$9.8M | -$11.8M | $39.1M |
| Cash From Investing | -$59,000 | -$5.2M | -$157,000 | -$37,000 | -$188,000 | -$25.2M |
| Cash From Financing | $38.7M | $0 | $348,000 | $7.8M | $6.6M | -$6.6M |
| Free Cash Flow | -$11.2M | -$14.9M | -$12.2M | -$9.9M | -$12.0M | $12.2M |
Figures from Ekso Bionics' 10-K and 10-Q filings with the SEC, as of 2026-10-14. Fiscal years follow the company's own reporting calendar. EPS and share counts are adjusted for later stock splits. See the full Ekso Bionics financials page for every line item.
Ekso Bionics Company Profile
| Ticker | EKSO |
|---|---|
| Exchange | Nasdaq |
| Industry | General Industrial Machinery & Equipment (Other) |
| Headquarters | Dallas, Texas |
| Incorporated in | Nevada |
| Fiscal Year End | December 31 |
| SEC Filer Category | Non-accelerated filer, smaller reporting company |
| SEC CIK | 0001549084 |
Frequently Asked Questions
What was Ekso Bionics' revenue in fiscal 2026?
Ekso Bionics (EKSO) reported revenue of $71.6M for fiscal 2026.
What is Ekso Bionics' annual revenue history?
Ekso Bionics' annual revenue by fiscal year: 2021: $11.2M; 2022: $12.9M; 2023: $18.3M; 2024: $17.9M; 2025: $12.8M; 2026: $71.6M.
What was Ekso Bionics' net income in fiscal 2026?
Ekso Bionics reported net income of -$50.3M for fiscal 2026.
What was Ekso Bionics' earnings per share (EPS) in fiscal 2026?
Ekso Bionics' diluted EPS was -$0.36 for fiscal 2026 (adjusted for any later stock splits).
How much free cash flow did Ekso Bionics generate in fiscal 2026?
Ekso Bionics generated $12.2M of free cash flow in fiscal 2026.
What was Ekso Bionics' revenue last quarter?
In its most recent reported quarter (2026 Q1), Ekso Bionics reported revenue of $2.1M.
How much debt does Ekso Bionics have?
Ekso Bionics reported $3.8M of long-term debt, including the current portion, at the end of fiscal 2026.
How many shares of Ekso Bionics are outstanding?
Ekso Bionics reported a weighted average of 3.6 million basic shares outstanding in 2026 Q1.
What is Ekso Bionics' market cap?
Based on its latest closing price, Ekso Bionics (EKSO) has a market capitalization of about $2.26B.
When does Ekso Bionics' fiscal year end?
Ekso Bionics' fiscal year end, as registered with the SEC, is December 31.
Where is Ekso Bionics headquartered?
Ekso Bionics lists its business address in Dallas, Texas in its SEC filings.